Hengkang Medical Group Co., Ltd. (002219.SZ)
CNY 2.82
(-1.74%)
CNY 2.82
(-1.74%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 291.23 Million | 268.03 Million | 277.29 Million | 283.79 Million | 549.51 Million | 522.56 Million |
| Net Income | 30.77 Million | 164.3 Million | -367.3 Million | -42.51 Million | -2.49 Billion | -1.38 Billion |
| Depreciation & Amortization | 238.65 Million | 166.52 Million | 163.28 Million | 170.65 Million | 134.54 Million | 230.4 Million |
| Deferred income taxes | -34.06 Million | -19.4 Million | -23.08 Million | 7.67 Million | 6.81 Million | -62.18 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -172.91 Million | -205.73 Million | -28.82 Million | 32.05 Million | 364.23 Million | 497.27 Million |
| Other non-cash items | 879.01 Million | 142.95 Million | 510.12 Million | 123.6 Million | 2.54 Billion | 1.18 Billion |
| Investing Cash Flow | -335.38 Million | -192.3 Million | -199.08 Million | -77.05 Million | -276.03 Million | -237.85 Million |
| Investments in PPE | -195.17 Million | -221.57 Million | -198.73 Million | -216.57 Million | -215.73 Million | -220.41 Million |
| Acquisitions | -139.21 Million | 49 Million | -1 Million | 115.32 Million | 2.5 Million | 3.48 Million |
| Investment purchases | -128.1 Million | -122.55 Million | -1 Million | -826.51 Thousand | -9.94 Million | -640 Thousand |
| Sales/Maturities of investments | 100 Thousand | 544.59 Thousand | 1 Million | 174.78 Thousand | 45.89 Million | 49.56 Thousand |
| Other Investing Activities | 127 Million | 102.27 Million | 643.98 Thousand | 24.84 Million | -98.74 Million | -20.33 Million |
| Financing Cash Flow | 62.82 Million | -1.52 Billion | 1.76 Billion | -174.65 Million | -585.59 Million | -550.97 Million |
| Debt repayment | -626.39 Million | -1.06 Billion | -284.73 Million | -494.56 Million | -1.53 Billion | -1.62 Billion |
| Dividends payments | -103.98 Million | -275.82 Million | -54.18 Million | -83.94 Million | -394.91 Million | -324.68 Million |
| Common Stock Repurchased | -19.51 Million | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -563.57 Million | -189.96 Million | 2.1 Billion | 403.85 Million | 1.34 Billion | 1.4 Billion |
| Accounts receivables | -195.6 Million | -160.13 Million | -70.23 Million | -14.09 Million | 761.44 Million | -1.17 Billion |
| Accounts payables | 74.94 Million | -47.04 Million | 71.76 Million | 61.95 Million | -471.58 Million | 1.37 Billion |
| Inventory | -52.25 Million | 20.84 Million | -7.26 Million | -23.47 Million | 67.55 Million | 359.98 Million |
| Other working capital | 40.88 Million | -19.4 Million | -23.08 Million | 7.67 Million | 6.81 Million | 137.29 Million |
| Cash at beginning of period | 559.37 Million | 1.99 Billion | 143.37 Million | 111.29 Million | 325.28 Million | 594.38 Million |
| Cash at end of period | 580.23 Million | 537.88 Million | 1.99 Billion | 143.37 Million | 111.29 Million | 325.28 Million |
| Capital Expenditure | -195.17 Million | -221.57 Million | -198.73 Million | -216.57 Million | -215.73 Million | -220.41 Million |
| Effect of forex changes on cash | 17.42 | 46.05 | -2.30 | 1.86 | 98.11 Million | -2.83 Million |
| Net cash flow / Change in cash | 20.85 Million | -1.45 Billion | 1.84 Billion | 32.08 Million | -213.99 Million | -269.09 Million |
| Free Cash Flow | 96.06 Million | 46.46 Million | 78.56 Million | 67.22 Million | 333.77 Million | 302.15 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.35 Million | 35.73 Million | 24.4 Million | -2.64 Million | 30.77 Million | -23.58 Million |
| Depreciation & Amortization | - | 50.07 Million | 50.07 Million | 71.91 Million | 238.65 Million | -79.37 Million |
| Deferred income taxes | - | - | - | 50.68 Million | -34.06 Million | -66.86 Million |
| Stock-based compensation | - | 52.12 Million | - | -39.06 Million | - | -39.06 Million |
| Change in working capital | - | -266.03 Million | - | -11.62 Million | -172.91 Million | 224.62 Million |
| Other non-cash items | 45.09 Million | 147.96 Million | -13.44 Million | 42.59 Million | 879.01 Million | 77.74 Million |
| Investing Cash Flow | -79.84 Million | -75.91 Million | -92.36 Million | -85.36 Million | -335.38 Million | -67.81 Million |
| Investments in PPE | -76.92 Million | -76.45 Million | -92.59 Million | -37.73 Million | -195.17 Million | -67.03 Million |
| Acquisitions | 1.27 Million | 531.44 Thousand | 203.54 Thousand | -48.47 Million | -139.21 Million | -1.45 Million |
| Investment purchases | -3 Million | - | - | -127.1 Million | -128.1 Million | -1 Million |
| Sales/Maturities of investments | - | - | - | 100 Thousand | 100 Thousand | 1 Million |
| Other Investing Activities | -2.92 Million | 1.73 Million | 235.75 Thousand | 127.84 Million | 127 Million | 668.82 Thousand |
| Financing Cash Flow | -85.15 Million | -76.79 Million | -7.24 Million | -42.13 Million | 62.82 Million | -45.9 Million |
| Debt repayment | -77.37 Million | -26.04 Million | -11.17 Million | -17.61 Million | -626.39 Million | -102.25 Million |
| Dividends payments | -20.41 Million | -41.18 Million | -21.1 Million | -42 Million | -103.98 Million | -18.8 Million |
| Common Stock Repurchased | - | - | - | -9.75 Million | -19.51 Million | -9.75 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 12.64 Million | -50.75 Million | 2.68 Million | -24.51 Million | -563.57 Million | 75.15 Million |
| Accounts receivables | - | -272.07 Million | - | 16.16 Million | -195.6 Million | 227.93 Million |
| Accounts payables | - | - | - | - | 74.94 Million | - |
| Inventory | - | 6.03 Million | - | -27.78 Million | -52.25 Million | -3.3 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 449.28 Million | 493.71 Million | 557.02 Million | 589.99 Million | 559.37 Million | 631.81 Million |
| Cash at end of period | 322.03 Million | 492.28 Million | 468.36 Million | 580.23 Million | 580.23 Million | 572.5 Million |
| Capital Expenditure | -76.92 Million | -76.45 Million | -92.59 Million | -37.73 Million | -195.17 Million | -67.03 Million |
| Effect of forex changes on cash | -11.92 | 9.11 | -2.54 | -10.12 | 17.42 | -8.03 |
| Net cash flow / Change in cash | -127.25 Million | -1.42 Million | -88.65 Million | -9.76 Million | 20.85 Million | -59.3 Million |
| Free Cash Flow | -39.17 Million | 57.17 Million | -81.64 Million | 74.13 Million | 96.06 Million | -12.61 Million |
NHLPF
JALL3
1301
ROMI3
FLNC
AN